Skip to content

Intravenous iron sucrose and sequential oral nutritional butter treatment in Tibetan patients with iron deficiency anemia

Intravenous iron sucrose and sequential oral nutritional butter treatment in Tibetan patients with iron deficiency anemia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048730
Enrollment
Unknown
Registered
2021-07-14
Start date
2020-06-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron-deficiency anemia

Interventions

Research Group:iron fortified nutritional butter

Sponsors

Shigatse Municipal People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. patients who live at an altitude of 3,000 meters for over two years; 2. Hb levels at the time of screening were 60.0 g/L to less than 120.0 g/L for females and 60.0 g/L to less than 130.0 g/L for males; 3. patients whose serum ferritin at the time of screening was lower than 30 ng/mL; 4. patients who were 18 years of age or older at the time of obtaining consent.

Exclusion criteria

Exclusion criteria: 1. patients with hematopoietic stem cell abnormality, globin synthesis disorder, increased erythrocyte destruction, erythropoietic disorder, chronic kidney disease, or inflammatory bowel disease; 2. patients who received intravenous or oral iron treatment within 4 weeks before screening; 3. patients who received blood formulations, erythropoiesis stimulation agent formulations within 8 weeks before screening; 4. woman during pregnancy.

Design outcomes

Primary

MeasureTime frame
Hb;

Countries

China

Contacts

Public ContactXiaoyang Li

Ruijin Hospital Afliated to Shanghai Jiao Tong University School of Medicine

lxy11811@rjh.com.cn+86 13917714328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026